Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION BP

Last updated on 2017-12-23 History
Report ID 32244
Drug Identification Number 02325594
Brand name CEFTRIAXONE SODIUM FOR INJECTION BP
Common or Proper name CEFTRIAXONE SODIUM FOR INJECTION BP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) CEFTRIAXONE
Strength(s) 250MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10 VIALS
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-12-08
Estimated end date 2018-01-08
Actual end date 2017-12-22
Shortage status Resolved
Updated date 2017-12-23
Company comments
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-12-23 French Compare
v5 2017-12-22 French Compare
v4 2017-12-22 English Compare
v3 2017-12-09 English Compare
v2 2017-12-08 French Compare
v1 2017-12-08 English Compare